Filter
37
Featured
New Publications
2
Language
Document type
No document type
30
Studies & Reports
3
Manuals
1
Resource Platforms
1
Guidelines
1
Strategic & Response Plan
1
Countries / Regions
Germany
2
Russia
2
Uganda
1
Ukraine
1
Western and Central Europe
1
Eastern Europe
1
Global
1
Authors & Publishers
Publication Years
Category
Countries
1
Since 1995, WHO has ensured a consistent approach to national, regional and global TB surveillance by providing standardized definitions, forms and registers for the recording and reporting of individual-level and aggregated data about people diagnosed with and treated for TB, which are used worldwi
...
Von den nachstehend aufgeführten Ärztinnen und Ärzten wird das "Beratungsnetzwerk Tuberkulose" des Bundesverbandes der Ärztinnen und Ärzte des Öffentlichen Gesundheitsdienstes (BVÖGD) unterhalten, das sich seit dem Jahr 2000 in der Praxis bewährt hat. Es wird – in Ergänzung vorhandener ü
...
The World Health Organization and the Global Fund to Fight AIDS, Tuberculosis and Malaria are part of a group of agencies working together to accelerate progress towards the health-related SDGs through the Global Action Plan for Healthy Lives and Well-being for All. Understanding patterns of inequal
...
The roadmap describes the actions needed to
achieve the three development goals for TB
vaccines set by the WHO:
1. A safe, effective and affordable TB vaccine
for adolescents and adults.
2. An affordable TB vaccine for neonates and
infants with improved safety and efficacy.
3. A therapeutic v
...
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
Screening programmes for tuberculosis (TB) among immigrants rarely consider the heterogeneity of
risk related to migrants’ country of origin. We assess the performance of a large screening programme in asylum seekers by analysing (i) the difference in yield and numbers needed to screen (NNS) by c
...
Int. J. Mol. Sci. 2017, 18, 341, 1 - 10
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
Eur Respir J 2017; 50: 1700918
Clinical Medicine
JCI Insight. 2017;2(7):e91963.
Lancet Respir Med 2017; 5: 291–360Vol, 5 April 2017
Trials (2017) 18:152, DOI 10.1186/s13063-017-1881-z
В настоящем отчете (это уже четвертое его издание) анализируются препятствия и факторы, затрудняющие доступ к препаратам для лечения лекарственно-устойчивого туб
...
The End TB Strategie
Eur Respir J 2016; 48: 808–817 | DOI: 10.1183/13993003.00840-2016
treat TB
Description of Research Outputs, 2009 - 2014
